Ark ETF Trust · net assets $1.24B · 33 holdings as of April 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.9% · STIV: 0.1%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $267M | $71.5M | $233M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $227M | $184M | $174M |
| Net realized gain (non-derivative) | $-6.17M | $-36.2M | $-21.4M |
| Net unrealized appreciation (non-derivative) | $-9.94M | $-104M | $156M |
The three months of the reporting period, as filed; month 3 ends April 30, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Tempus Ai Inc EC | $116M | 9.42% |
| Twist Bioscience Corp EC | $111M | 8.99% |
| Crispr Therapeutics Ag EC | $110M | 8.91% |
| 10x Genomics Inc EC | $71.3M | 5.77% |
| Beam Therapeutics Inc EC | $67.1M | 5.43% |
| Absci Corp EC | $59.1M | 4.78% |
| Natera Inc EC | $50.2M | 4.07% |
| Illumina Inc EC | $49.8M | 4.03% |
| Intellia Therapeutics Inc EC | $47.2M | 3.82% |
| Personalis Inc EC | $44.3M | 3.58% |
| Recursion Pharmaceuticals Inc EC | $43.4M | 3.51% |
| Guardant Health Inc EC | $43.2M | 3.49% |
| Caredx Inc EC | $41.8M | 3.38% |
| Veracyte Inc EC | $32.9M | 2.66% |
| Compass Pathways PLC EC | $30M | 2.43% |
| Adaptive Biotechnologies Corp EC | $29.9M | 2.42% |
| Nurix Therapeutics Inc EC | $28.8M | 2.33% |
| Genedx Holdings Corp EC | $25.2M | 2.04% |
| Schrodinger Inc EC | $25M | 2.03% |
| Arcturus Therapeutics Holdings Inc EC | $24.2M | 1.96% |
| Butterfly Network Inc EC | $23.4M | 1.89% |
| Ionis Pharmaceuticals Inc EC | $21.5M | 1.74% |
| Ataibeckley Inc EC | $18.2M | 1.48% |
| Prime Medicine Inc EC | $17.5M | 1.41% |
| Pacific Biosciences Of California Inc EC | $17.4M | 1.41% |
| Cerus Corp EC | $15.1M | 1.22% |
| Alamar Biosciences Inc EC | $14.9M | 1.21% |
| 908 Devices Inc EC | $13.3M | 1.08% |
| Biontech Se EC | $13.1M | 1.06% |
| Eli Lilly & Company EC | $11.7M | 0.95% |
| Quantum-si Inc EC | $6.79M | 0.55% |
| Generate Biomedicines Inc EC | $6.36M | 0.51% |
| Goldman Sachs Financial Square Treasury Obligations Fund STIV | $1.58M | 0.13% |
Loading...
